Bae P. Chu
YOU?
Author Swipe
View article: Extravasation Frequency of [<sup>177</sup>Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients—A Single-Site Analysis
Extravasation Frequency of [<sup>177</sup>Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients—A Single-Site Analysis Open
Extravasation of radiopharmaceuticals raises potential concerns, including adverse tissue reactions and reduction in both quantitative accuracy and therapeutic efficacy. This study presents a single-center experience reviewing extravasatio…
View article: The relationship between intradialytic hypotension and health-related quality of life in patients undergoing hemodialysis: a cross-sectional study
The relationship between intradialytic hypotension and health-related quality of life in patients undergoing hemodialysis: a cross-sectional study Open
The health-related quality of life (HRQOL) of hemodialysis patients is significantly lower than that of age-matched counterparts. As one of the most common and serious complications of hemodialysis, intradialytic hypotension was associated…
View article: Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease Open
Background Radiolabeled antibody 131 I-omburtamab was administered intraventricularly in patients with leptomeningeal disease under an institutionally approved study (# NCT03275402 ). Radiation safety precautions were tailored for individu…
View article: Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease Open
View article: Yttrium-90 Activity Quantification in PET/CT–Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro–CT and Autoradiography
Yttrium-90 Activity Quantification in PET/CT–Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro–CT and Autoradiography Open
View article: Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies Open
View article: SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX
SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX Open
External dose rates were measured 1 m away from 230 Lu-177 patients to characterise the variability in normalised dose rates as a function of administered activity, body mass index (BMI) and sex. The largest dose rate observed was 0.07 mSv…
View article: Patient‐specific radiological protection precautions following Cs collagen embedded Cs‐131 implantation in the brain
Patient‐specific radiological protection precautions following Cs collagen embedded Cs‐131 implantation in the brain Open
Objective Cesium‐131 brachytherapy is an adjunct for brain tumor treatment, offering potential clinical and radiation protection advantages over other isotopes including iodine‐125. We present evidence‐based radiation safety recommendation…
View article: Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides
Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides Open
CE credit: For CE credit, you can access the test for this article, as well as additional JNMT CE tests, online at https://www.snmmilearningcenter.org Complete the test online no later than March 2025. Your online test will b…
View article: Attenuation of Gamma Radiation Using ClearView Radiation ShieldingTM in Nuclear Power Plants, Hospitals and Radiopharmacies
Attenuation of Gamma Radiation Using ClearView Radiation ShieldingTM in Nuclear Power Plants, Hospitals and Radiopharmacies Open
Radiation protection materials, such as lead (Pb), water, concrete, steel, and aluminum, have been successfully used for decades. Although they are effective shields, these materials do have limitations. For example, lead is heavy and toxi…
View article: 69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE
69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE Open
OBJECTIVE Recurrence of previously-irradiated brain metastases (BrM) presents a significant challenge. We describe our initial experience using salvage resection with Cs131 brachytherapy in previously-irradiated BrM. METHODS Between Septem…
View article: Feasibility of Administering Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Conditioning in Older Patients with Active, Relapsed or Refractory AML without Lead-Lined Rooms: Ongoing Phase III Sierra Trial Experience at 6 Study Sites
Feasibility of Administering Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Conditioning in Older Patients with Active, Relapsed or Refractory AML without Lead-Lined Rooms: Ongoing Phase III Sierra Trial Experience at 6 Study Sites Open
IntroductionPatients ≥55 years of age with active, relapsed or refractory acute myeloid leukemia (AML) who have failed standard induction and salvage therapies do not routinely undergo allogeneic hematopoietic cell transplantation due to t…
View article: Radiological protection for pregnant women at a large academic medical Cancer Center
Radiological protection for pregnant women at a large academic medical Cancer Center Open
View article: Feasibility of Administering High-Dose<sup>131</sup>I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms
Feasibility of Administering High-Dose<sup>131</sup>I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms Open
Although (131) I-metaiodobenzylguanidine ((131) I-MIBG) therapy is increasingly used for children with high-risk neuroblastoma, a paucity of lead-lined rooms limits its wider use. We implemented radiation safety procedures to comply with N…